sio Weekly Update MultiBriefs
Contact Us
Media Kit

Browse Categories

Browse by Date

Search past issues
Search products and services

As the field of interventional oncology continues to advance, so does the necessity to stay ahead of the...

source: SIO

Next month the 4th China Conference on Microwave Ablation (CCMA 2019) and the 2nd SIO Symposium on Tumor...

source: SIO

SIO 2019 brings you the opportunity to share your research with more than 700 professionals in the global...

source: SIO

PURPOSE: Despite being accepted as a mainstay of treatment for hepatocellular carcinoma (HCC), technical aspects of transarterial chemoembolization (TACE) continue to vary by reporting author, leading...

source: European Radiology

PURPOSE: To compare the efficacies of transarterial chemoembolization (TACE) combined with radiofrequency ablation (RFA) with hepatectomy. Prognostic factors for the patient groups were...

source: Cancer Management and Research

Prognosis remains poor for hepatocellular carcinoma (HCC) patients with extrahepatic metastases (EHMs). This study aimed to develop a nomogram to predict EHMs in HCC patients who underwent adjuvant transarterial...

source: Journal of Cancer


Powered by MultiBriefs
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063

Subscribe to IO Insights

*First Name:
*Last Name:
Street Address:
State / Province:
Zip / Postal Code:
Are you a member of SIO? Yes   No
Privacy Policy